In the pipeline: What the next wave of COVID-19 vaccines could look like
We take a look at some of the COVID-19 vaccine candidates moving through clinical trials.
We take a look at some of the COVID-19 vaccine candidates moving through clinical trials.
A new type of self-injecting capsule could deliver medications at comparable levels to those given via injection, according to a preclinical study.
Seattle-based Umoja Biopharma, a company looking to reprogram immune cells in-vivo to create next-generation immunotherapies for the treatment of solid tumors and hematologic malignancies, has started work on its new development and manufacturing...
Boston-based company, Vertex, has signed a deal to use Arbor Biotechnologies’ CRISPR gene-editing technology to develop novel cell therapies for the treatment of serious diseases.